MS Speaks

Multiple Sclerosis => TREATMENTS => TYSABRI (natalizumab) => Topic started by: agate on October 25, 2019, 07:56:09 pm

Title: Natalizumab and liver injury research information (PubMed)
Post by: agate on October 25, 2019, 07:56:09 pm
The Overview section of segment on natalizumab in the report entitled "LiverTox: Clinical and research information on drug-induced liver injury" from the National Institute of Diabetes and Digestive and Kidney Diseases. There is apparently no "likelihood score" (defined as "likely cause of clinically apparent liver injury") included for natalizumab.


https://www.ncbi.nlm.nih.gov/books/NBK548623/#Natalizumab.OVERVIEW